Literature DB >> 24913981

Dual function of CD70 in viral infection: modulator of early cytokine responses and activator of adaptive responses.

Atef Allam1, Melissa Swiecki1, William Vermi2, Jonathan D Ashwell3, Marco Colonna4.   

Abstract

The role of the TNF family member CD70 in adaptive T cell responses has been intensively studied, but its function in innate responses is still under investigation. In this study, we show that CD70 inhibits the early innate response to murine CMV (MCMV) but is essential for the optimal generation of virus-specific CD8 T cells. CD70(-/-) mice reacted to MCMV infection with a robust type I IFN and proinflammatory cytokine response. This response was sufficient for initial control of MCMV, although at later time points, CD70(-/-) mice became more susceptible to MCMV infection. The heightened cytokine response during the early phase of MCMV infection in CD70(-/-) mice was paralleled by a reduction in regulatory T cells (Treg). Treg from naive CD70(-/-) mice were not as efficient at suppressing T cell proliferation compared with Treg from naive wild-type mice, and depletion of Treg during MCMV infection in Foxp3-diphtheria toxin receptor mice or in wild-type mice recapitulated the phenotype observed in CD70(-/-) mice. Our study demonstrates that although CD70 is required for the activation of the antiviral adaptive response, it has a regulatory role in early cytokine responses to viruses such as MCMV, possibly through maintenance of Treg survival and function.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24913981      PMCID: PMC4241374          DOI: 10.4049/jimmunol.1302429

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  CD27 is required for generation and long-term maintenance of T cell immunity.

Authors:  J Hendriks; L A Gravestein; K Tesselaar; R A van Lier; T N Schumacher; J Borst
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

2.  CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

Authors:  Pau Serra; Abdelaziz Amrani; Jun Yamanouchi; Bingye Han; Shari Thiessen; Toshihiro Utsugi; Joan Verdaguer; Pere Santamaria
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

3.  Signaling through CD70 regulates B cell activation and IgG production.

Authors:  Ramon Arens; Martijn A Nolte; Kiki Tesselaar; Bianca Heemskerk; Kris A Reedquist; René A W van Lier; Marinus H J van Oers
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

4.  Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells.

Authors:  Namita Misra; Jagadeesh Bayry; Sébastien Lacroix-Desmazes; Michel D Kazatchkine; Srini V Kaveri
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

5.  In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures.

Authors:  Wayne R Godfrey; Ying G Ge; Darrin J Spoden; Bruce L Levine; Carl H June; Bruce R Blazar; Stephen B Porter
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

6.  Modulation of tryptophan catabolism by regulatory T cells.

Authors:  Francesca Fallarino; Ursula Grohmann; Kwang Woo Hwang; Ciriana Orabona; Carmine Vacca; Roberta Bianchi; Maria Laura Belladonna; Maria Cristina Fioretti; Maria-Luisa Alegre; Paolo Puccetti
Journal:  Nat Immunol       Date:  2003-10-26       Impact factor: 25.606

7.  Expression of the murine CD27 ligand CD70 in vitro and in vivo.

Authors:  Kiki Tesselaar; Yanling Xiao; Ramon Arens; Gijs M W van Schijndel; Danita H Schuurhuis; Reina E Mebius; Jannie Borst; René A W van Lier
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

Review 8.  Pathogenesis of murine cytomegalovirus infection.

Authors:  Astrid Krmpotic; Ivan Bubic; Bojan Polic; Pero Lucin; Stipan Jonjic
Journal:  Microbes Infect       Date:  2003-11       Impact factor: 2.700

9.  IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells.

Authors:  Georg Gasteiger; Saskia Hemmers; Matthew A Firth; Audrey Le Floc'h; Morgan Huse; Joseph C Sun; Alexander Y Rudensky
Journal:  J Exp Med       Date:  2013-05-06       Impact factor: 14.307

10.  CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool.

Authors:  Jenny Hendriks; Yanling Xiao; Jannie Borst
Journal:  J Exp Med       Date:  2003-10-27       Impact factor: 14.307

View more
  8 in total

1.  Tregs strip dendritic cells of CD70 to regulate Th1 differentiation.

Authors:  Lukasz Wojciech; Leszek Ignatowicz
Journal:  EMBO J       Date:  2015-04-13       Impact factor: 11.598

2.  T Cell-Derived CD70 Delivers an Immune Checkpoint Function in Inflammatory T Cell Responses.

Authors:  Rachel E O'Neill; Wei Du; Hemn Mohammadpour; Emad Alqassim; Jingxin Qiu; George Chen; Philip L McCarthy; Kelvin P Lee; Xuefang Cao
Journal:  J Immunol       Date:  2017-10-18       Impact factor: 5.422

3.  CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.

Authors:  Cheng Ye; Benjamin E Low; Michael V Wiles; Todd M Brusko; David V Serreze; John P Driver
Journal:  J Immunol       Date:  2020-08-31       Impact factor: 5.422

4.  CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy.

Authors:  Anna Wasiuk; James Testa; Jeff Weidlick; Crystal Sisson; Laura Vitale; Jenifer Widger; Andrea Crocker; Lawrence J Thomas; Joel Goldstein; Henry C Marsh; Tibor Keler; Li-Zhen He
Journal:  J Immunol       Date:  2017-11-06       Impact factor: 5.422

5.  Cell type-specific properties and environment shape tissue specificity of cancer genes.

Authors:  Martin H Schaefer; Luis Serrano
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

6.  CD70 Deficiency due to a Novel Mutation in a Patient with Severe Chronic EBV Infection Presenting As a Periodic Fever.

Authors:  Roberta Caorsi; Marta Rusmini; Stefano Volpi; Sabrina Chiesa; Claudia Pastorino; Angela Rita Sementa; Paolo Uva; Alice Grossi; Edoardo Lanino; Maura Faraci; Francesca Minoia; Sara Signa; Paolo Picco; Alberto Martini; Isabella Ceccherini; Marco Gattorno
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

7.  Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.

Authors:  Hassan Abolhassani; Emily S J Edwards; Aydan Ikinciogullari; Huie Jing; Stephan Borte; Marcus Buggert; Likun Du; Mami Matsuda-Lennikov; Rosa Romano; Rozina Caridha; Sangeeta Bade; Yu Zhang; Juliet Frederiksen; Mingyan Fang; Sevgi Kostel Bal; Sule Haskologlu; Figen Dogu; Nurdan Tacyildiz; Helen F Matthews; Joshua J McElwee; Emma Gostick; David A Price; Umaimainthan Palendira; Asghar Aghamohammadi; Bertrand Boisson; Nima Rezaei; Annika C Karlsson; Michael J Lenardo; Jean-Laurent Casanova; Lennart Hammarström; Stuart G Tangye; Helen C Su; Qiang Pan-Hammarström
Journal:  J Exp Med       Date:  2016-12-23       Impact factor: 14.307

8.  CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.

Authors:  Mathieu Seyfrid; William Thomas Maich; Vaseem Muhammad Shaikh; Nazanin Tatari; Deepak Upreti; Deween Piyasena; Minomi Subapanditha; Neil Savage; Dillon McKenna; Nicholas Mikolajewicz; Hong Han; Chirayu Chokshi; Laura Kuhlmann; Amanda Khoo; Sabra Khalid Salim; Blessing Archibong-Bassey; William Gwynne; Kevin Brown; Nadeem Murtaza; David Bakhshinyan; Parvez Vora; Chitra Venugopal; Jason Moffat; Thomas Kislinger; Sheila Singh
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.